[2014-Dec-19] FDA approves Lynparza to treat advanced ovarian cancer
[2014-Dec-19] FDA approves Lynparza to treat advanced ovarian cancer
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm427554.htm
Lynparza.cdx
Keith A. Menear, Claire Adcock, Robert Boulter, Xiao-ling Cockcroft, Louise Copsey, Aaron Cranston, Krystyna J. Dillon, Jan Drzewiecki, Sheila Garman, Sylvie Gomez, Hashim Javaid, Frank Kerrigan, Charlotte Knights, Alan Lau, Vincent M. Loh , Jr., Ian T. W. Matthews, Stephen Moore, Mark J. O’Connor, Graeme C. M. Smith and Niall M. B. Martin, 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1, J. Med. Chem., 2008, 51 (20), pp 6581–6591
http://dx.doi.org/10.1021/jm8001263
Valérie Schreiber, Françoise Dantzer, Jean-Christophe Ame and Gilbert de Murcia, Poly(ADP-ribose): novel functions for an old molecule, Nat. Rev. Mol. Cell Biol., 2006, 7 (7), pp 517-528
http://dx.doi.org/10.1038/nrm1963
Prakash Jagtap and Csaba Szabó, Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors, Nat. Rev. Drug Discov., 2005, 4 (5), 421-440